In-hospital outcome differences between transradial and transfemoral coronary approaches: Data from the Korean

Sung Gyun Ahn1, Jun-Won Lee1, Young Jin Youn1

  • 1Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital, Wonju, Republic of Korea.

Insights

Transradial coronary interventions (TRIs) show better in-hospital outcomes than transfemoral approaches, especially for high-risk patients and in high-volume centers. These findings support TRI as a preferred method in specific clinical scenarios.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Vascular Access

Background:

  • Transradial coronary interventions (TRIs) offer potential advantages over transfemoral coronary interventions (TFIs).
  • The comparative benefit of TRIs versus TFIs may vary based on clinical context, procedure urgency, and operator experience.
  • Identifying specific patient subgroups that benefit most from TRIs is crucial for optimizing outcomes.

Purpose of the Study:

  • To investigate specific patient subgroups where transradial coronary interventions (TRIs) demonstrate enhanced benefits compared to transfemoral coronary interventions (TFIs).
  • To analyze in-hospital outcomes and identify factors influencing the efficacy of TRIs.

Main Methods:

  • A retrospective analysis of the 2014 Korean Percutaneous Coronary Intervention Registry.
  • Propensity score matching was used to compare in-hospital outcomes between 22,993 patients undergoing TRI and 15,581 patients undergoing TFI.
  • Composite endpoints including all-cause death, nonfatal myocardial infarctions (MIs), and transfusions were analyzed in the overall cohort and specific subgroups.

Main Results:

  • TRIs were associated with significantly lower composite endpoints compared to TFIs (2.1% vs. 5.5%).
  • The TRI group showed reduced rates of death (OR 0.44) and nonfatal MI (OR 0.66), and required fewer transfusions (OR 0.72).
  • Benefits of TRI were consistent across most subgroups, with greater advantages observed in the elderly (≥75 years), ST-elevation MI patients, emergent PCI cases, and high PCI volume centers. Reduced benefits were noted in patients with chronic kidney disease and those treated in low-volume centers.

Conclusions:

  • Transradial coronary interventions (TRIs) yield superior composite in-hospital outcomes compared to transfemoral coronary interventions (TFIs).
  • The advantages of TRIs are particularly pronounced in high-risk clinical settings and high percutaneous coronary intervention (PCI) volume hospitals.
  • These findings highlight the importance of procedural approach selection based on patient risk factors and institutional capacity.
Abstract

Related Concept Videos

Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
428
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
975
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
325
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267